OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review
M. N. A. Mandal, Pawan Jaiswal, Awanish Mishra
Journal of Biochemical and Molecular Toxicology (2020) Vol. 34, Iss. 6
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders
Priti Tagde, Pooja Tagde, Fahadul Islam, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7109-7109
Open Access | Times Cited: 124

Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases
Rachel J. Boyd, Dimitri Avramopoulos, Lauren L. Jantzie, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 78

Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Awanish Mishra, Ritam Bandopadhyay, Prabhakar Singh, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1591-1626
Closed Access | Times Cited: 99

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology
Umair Shabbir, Momna Rubab, Akanksha Tyagi, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 196-196
Open Access | Times Cited: 88

Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson’s disease by modulating α-synuclein aggregation and reactive oxygen species
Lei Li, Qiuxia Tu, Xiaohe Zhang, et al.
Chemical Engineering Journal (2023) Vol. 461, pp. 141606-141606
Closed Access | Times Cited: 26

Phytomedicine for neurodegenerative diseases: The road ahead
Dev Madhubala, Aparup Patra, Mojibur R. Khan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2993-3019
Closed Access | Times Cited: 11

Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
Gagandeep Maan, Biplab Sikdar, Ashish Kumar, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 13, pp. 1169-1194
Closed Access | Times Cited: 67

Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates
Aroa Duro‐Castaño, Consuelo Borrás, Vicente Herranz‐Pérez, et al.
Science Advances (2021) Vol. 7, Iss. 13
Open Access | Times Cited: 47

Current clinical developments in curcumin‐based therapeutics for cancer and chronic diseases
Aviral Kumar, Choudhary Harsha, Parama Dey, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6768-6801
Closed Access | Times Cited: 43

Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial
Hamidreza Ghodsi, Hamid Reza Rahimi, Seyedeh Mehrnaz Aghili, et al.
Clinical Neurology and Neurosurgery (2022) Vol. 218, pp. 107300-107300
Closed Access | Times Cited: 34

Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 299-331
Open Access | Times Cited: 33

Curcumin Release from Biomaterials for Enhanced Tissue Regeneration Following Injury or Disease
Adelle E. Hamilton, Ryan J. Gilbert
Bioengineering (2023) Vol. 10, Iss. 2, pp. 262-262
Open Access | Times Cited: 22

On the health effects of curcumin and its derivatives
Hudda Ayub, Mahad Islam, Munnaza Saeed, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 11, pp. 8623-8650
Open Access | Times Cited: 6

A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory
Júlia Novaes Matias, Gabriela Achete de Souza, Gyovanna Sorrentino dos Santos Campanari, et al.
Australian & New Zealand Journal of Psychiatry (2021) Vol. 55, Iss. 5, pp. 451-462
Closed Access | Times Cited: 40

Curcumin Loaded PEGylated Nanoemulsions Designed for Maintained Antioxidant Effects and Improved Bioavailability: A Pilot Study on Rats
Jelena Đoković, Sanela Savić, Jelena R. Mitrović, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7991-7991
Open Access | Times Cited: 33

Application of curcumin nanoformulations in Alzheimer’s disease: prevention, diagnosis and treatment
Hongqian Lv, Yan Wang, Xiaotong Yang, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 8, pp. 727-742
Closed Access | Times Cited: 27

Mechanisms Underlying Curcumin-Induced Neuroprotection in Cerebral Ischemia
Fan Feng, Lei Meng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24

Effect of hesperidin on fluoride‐induced neurobehavioral and biochemical changes in rats
Pawan Jaiswal, M. N. A. Mandal, Awanish Mishra
Journal of Biochemical and Molecular Toxicology (2020) Vol. 34, Iss. 11
Closed Access | Times Cited: 35

Phytochemicals in the Management of Arsenic Toxicity
Sabiya Samim Khan, Ankita Sharma, S.J.S. Flora
Chemical Research in Toxicology (2022) Vol. 35, Iss. 6, pp. 916-934
Closed Access | Times Cited: 22

Nanogels, nanodiscs, yeast cells, and metallo-complexes-based curcumin delivery for therapeutic applications
Mohsen Rahmanian, Fatemeh Oroojalian, Elham Pishavar, et al.
European Polymer Journal (2023) Vol. 196, pp. 112215-112215
Closed Access | Times Cited: 11

Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations
Ersin Karataylı, Sadiq Sani, Jörn M. Schattenberg, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 484-484
Open Access

Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study
Debora Santonocito, Maria Grazia Sarpietro, Claudia Carbone, et al.
Molecules (2020) Vol. 25, Iss. 13, pp. 2991-2991
Open Access | Times Cited: 31

Encapsulation of curcumin in CD-MOFs: promoting its incorporation into water-based products and consumption
Qianyu Sun, Jie Sheng, Rendang Yang
Food & Function (2021) Vol. 12, Iss. 21, pp. 10795-10805
Closed Access | Times Cited: 25

Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders
Pratikeswar Panda, Sanjib Mohanty, Sangita Ranee Gouda, et al.
Nutritional Neuroscience (2025), pp. 1-26
Closed Access

Page 1 - Next Page

Scroll to top